BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Novartis
UBS
Fuji
Federal Trade Commission
Moodys
Citi
Harvard Business School
Queensland Health

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,538,125

« Back to Dashboard

Summary for Patent: 7,538,125
Title:Pharmaceutical composition
Abstract:Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.
Inventor(s): Ikeda; Hitoshi (Osaka, JP), Sohda; Takashi (Osaka, JP), Odaka; Hiroyuki (Hyogo, JP)
Assignee: Takeda Pharmaceutical Company Limited (Osaka, JP)
Application Number:11/523,771
Patent Claim Types:
see list of patent claims
Composition; Dosage form;

Drugs Protected by US Patent 7,538,125

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 7,538,125

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan1995-153500Jun 20, 1995

International Patents Family Members for US Patent 7,538,125

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 005641 ➤ Subscribe
Argentina 061195 ➤ Subscribe
Argentina 065389 ➤ Subscribe
Argentina 091289 ➤ Subscribe
Austria 256463 ➤ Subscribe
Austria 438397 ➤ Subscribe
Australia 5603496 ➤ Subscribe
Australia 723097 ➤ Subscribe
Canada 2179584 ➤ Subscribe
Canada 2531834 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Covington
McKesson
Fish and Richardson
Moodys
Chinese Patent Office
Healthtrust
Julphar
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot